- Lobbying
- Lobbying by OptiNose
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Mike Merola | Deputy CoS, Sen. Torricelli |
Donna Mullins | CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa |
Chelsey Hickman | CoS, Rep. Kay Granger; LA Sen. Larry Craig |
Rob Zucker | LD, Rep. Rothman; LA, Rep. Evans (IL); Sen. Lautenberg |
Nancy Fox | Staff Director House Appropriations Committee, Chief of Staff Rep. Rodney Frelinghuysen (NJ), Scheduler Rep. Marge Roukema (NJ), Scheduler Rep. Silvio O. Conte (MA) Staff Director House Appropriations Committee, Chief of Staff Rep. Rodney Frelinghuysen (NJ) Scheduler Rep. Marge Roukema (NJ), Scheduler Rep. Silvio O. Conte (MA) |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q3 Report
Termination
Q2 Report
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Defense - Dept of (DOD)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Health & Human Services - Dept of (HHS)
Defense - Dept of (DOD)
Natl Institutes of Health (NIH)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Defense - Dept of (DOD)
Food & Drug Administration (FDA)
Type of Issue
Registration
Issue(s) they said they’d lobby about: COVID 19 regulatory approvals and relief legislation.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate